Company Filing History:
Years Active: 2019
Title: Innovations in Male Fertility: The Contributions of Ma Empar Chenoll Cuadros
Introduction
Ma Empar Chenoll Cuadros is an innovative inventor based in Paterna, Spain. She has made significant contributions to the field of male fertility through her research and inventions. Her work focuses on the use of probiotics to enhance male fertility, showcasing her commitment to advancing reproductive health.
Latest Patents
Ma Empar Chenoll Cuadros holds a patent for the "Use of probiotics to increase male fertility." This invention relates to the formulation that combines specific probiotic strains, namely CECT 8361 and CECT 7347, to improve male fertility in subjects. The formulation described in her patent highlights the potential of these strains in addressing fertility issues.
Career Highlights
Throughout her career, Ma Empar has worked with notable institutions, including Universidad De León and Biopolis, S.L. Her experience in these organizations has allowed her to collaborate with other experts in the field and contribute to significant advancements in reproductive health.
Collaborations
Ma Empar has collaborated with professionals such as Vanesa Robles Rodríguez and David García Valcarce. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Ma Empar Chenoll Cuadros is a pioneering inventor whose work in probiotics and male fertility is making a difference in reproductive health. Her innovative approach and dedication to research continue to inspire advancements in this important field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.